PortfoliosLab logo

Bellicum Pharmaceuticals, Inc. (BLCM)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Bellicum Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $17 for a total return of roughly -99.83%. All prices are adjusted for splits and dividends.

BLCM (Bellicum Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BLCM

Bellicum Pharmaceuticals, Inc.


Bellicum Pharmaceuticals, Inc. had a return of -44.44% year-to-date (YTD) and -77.01% in the last 12 months. Over the past 10 years, Bellicum Pharmaceuticals, Inc. had an annualized return of -54.01%, while the S&P 500 had an annualized return of 8.11%, indicating that Bellicum Pharmaceuticals, Inc. did not perform as well as the benchmark.

1 month-66.39%-5.31%
6 months-70.37%0.39%
1 year-77.01%-10.12%
5 years (annualized)-65.34%7.32%
10 years (annualized)-54.01%8.11%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bellicum Pharmaceuticals, Inc. Sharpe ratio is -0.74. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BLCM (Bellicum Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History

Bellicum Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BLCM (Bellicum Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Bellicum Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bellicum Pharmaceuticals, Inc. is 99.87%, recorded on Mar 17, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.87%Jan 12, 20152060Mar 17, 2023
-19.93%Dec 19, 20143Dec 23, 20147Jan 5, 201510

Volatility Chart

Current Bellicum Pharmaceuticals, Inc. volatility is 377.76%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BLCM (Bellicum Pharmaceuticals, Inc.)
Benchmark (^GSPC)